KNC Laboratories Co Ltd
TSE:6568
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (1), the stock would be worth ¥1 022.86 (20% downside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.3 | ¥1 281 |
0%
|
| 3-Year Average | 1 | ¥1 022.86 |
-20%
|
| 5-Year Average | 1.1 | ¥1 059.38 |
-17%
|
| Industry Average | 0.9 | ¥854.83 |
-33%
|
| Country Average | 1.1 | ¥1 106.4 |
-14%
|
Forward EV/S
Today’s price vs future revenue
| Today's Enterprise Value | Revenue | Forward EV/S | ||
|---|---|---|---|---|
|
¥11B
|
/ |
Jan 2026
¥8.5B
|
= |
|
|
¥11B
|
/ |
Mar 2026
¥11.8B
|
= |
|
|
¥11B
|
/ |
Mar 2027
¥14.1B
|
= |
|
Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
KNC Laboratories Co Ltd
TSE:6568
|
9.9B JPY | 1.3 | 19.7 | |
| SA |
|
Saudi Basic Industries Corporation SJSC
SAU:2010
|
228.3B SAR | 1.8 | -8.8 | |
| ID |
|
Chandra Asri Pacific PT Tbk
OTC:PTPIF
|
45.6B USD | 6.8 | 41.8 | |
| US |
|
Dow Inc
NYSE:DOW
|
29B USD | 1.1 | -11 | |
| ID |
|
Chandra Asri Petrochemical Tbk PT
IDX:TPIA
|
458.5T IDR | 4.1 | 24.8 | |
| UK |
|
LyondellBasell Industries NV
NYSE:LYB
|
24B USD | 1.1 | -32 | |
| TW |
|
Nan Ya Plastics Corp
TWSE:1303
|
726.5B TWD | 3.1 | 160.8 | |
| CN |
|
Hengli Petrochemical Co Ltd
SSE:600346
|
156.4B CNY | 1.4 | 17.5 | |
| KR |
|
LG Chem Ltd
KRX:051910
|
31.9T KRW | 1 | -17.1 | |
| CN |
|
Rongsheng Petrochemical Co Ltd
SZSE:002493
|
136.3B CNY | 0.9 | 185.1 | |
| CN |
G
|
Guangzhou Tinci Materials Technology Co Ltd
SZSE:002709
|
120.7B CNY | 6 | 42.1 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.7 |
| Median | 1.1 |
| 70th Percentile | 2 |
| Max | 12 107 466 |
Other Multiples
KNC Laboratories Co Ltd
Glance View
KNC Laboratories Co., Ltd. engages in research, development, and production solutions for organic chemicals. The company is headquartered in Kobe, Hyogo-Ken and currently employs 282 full-time employees. The company went IPO on 2018-03-15. The firm supplies necessary samples and products for research, development and production activities for product development, manufacture and sale, and also examines the manufacturing method. Organic chemical products are chemical products and intermediates used in the field of medicine and information electronics. Products include display materials, chemicals for semiconductor manufacturing, herbicides, fungicides, drug substances and intermediates, among others.
